The largest database of trusted experimental protocols

Cobas fara centrifugal analyser

Manufactured by Roche
Sourced in United Kingdom

The Cobas Fara centrifugal analyzer is a laboratory instrument used for automated chemical analysis. It performs various clinical chemistry tests by mixing and analyzing small samples of patient fluids, such as blood or urine. The Cobas Fara utilizes a centrifugal mechanism to separate and process the samples, providing efficient and accurate results for a range of diagnostic tests.

Automatically generated - may contain errors

4 protocols using cobas fara centrifugal analyser

1

Oral Glucose Tolerance in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
For F0 and F1 animals, one animal per litter underwent oral glucose tolerance testing (OGTT) (F0 n = 9, F1 n = 5–6). For F2 animals, two animals from each litter were tested (n = 8–14 from 4–7 litters). Following an overnight fast, at 09.00, blood was obtained by tail nicking into EDTA coated micro tubes (Starstedt, Germany) and plasma separated. 2 g/kg of 0.5 g/ml glucose solution (Sigma) was administered by oral gavage. Further blood was collected at 30 and 120 min.
For F0 animals, glucose was measured using a colorimetric kit (Cayman, USA) and for F1 and F2 with a kit (Alpha Laboratories Ltd., UK) adapted for use on a Cobas Fara centrifugal analyser (Roche, UK). Insulin was measured using a Rat Insulin ELISA kit (Mercodia, Sweden,). Fasting plasma triglyceride and cholesterol were determined using kits (Alpha Laboratories Ltd., UK and Olympus Diagnostics Ltd, UK, respectively), adapted for use on a Cobas Fara centrifugal analyser (Roche, UK). Terminal plasma leptin was measured using a Rat Leptin ELISA (Crystal-Chem, IL, USA).
+ Open protocol
+ Expand
2

Urine and Serum Creatinine Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
Urine and serum creatinine concentrations were measured using the creatinase reaction, with the exception of the first cohort of the model evaluation studies where Jaffe reaction was used (for the Podo-DTR line 47 given 1ng/g DT). Serum urea was measured using the urease reaction (Alpha Laboratory Ltd, Poole, UK). An immunoturbidimetric assay was developed to measure urinary mouse albumin concentration using a commercial diagnostic Microalbumin Kit (Olympus Diagnostic Ltd, Watford, UK) standardised against purified mouse albumin (Sigma Chemical Co. Poole, UK). All the assays were adapted for use on a Cobas Fara centrifugal analyser (Roche diagnostics Ltd, Welwyn Garden City, UK) according to manufacturer’s instructions.
+ Open protocol
+ Expand
3

Plasma and Serum Amylase Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
At 4.5 hours after AP induction blood was collected from the femoral artery catheter in a heparinzed syringe and centrifuged (Denville 260D; Denville Scientific; Metuchen, NJ) at 3000 rpf for 10 min at 4 °C to generate plasma. Amylase was measured by ELISA (QuantiChrom α-amylase Assay Kit, BioAssay Systems, Hayward, CA) according the manufacturer's instructions and expressed as IU/L. Mouse blood was left at room temperature for 30 minustes then microcentrifuged at 5000 × g for 10 minutes to generate serum. Serum aliquots were stored at -80 °C. Serum amylase activity was measured using a commercial kit (Alpha Laboratories Ltd., Eastleigh, UK) adapted for use on a Cobas Fara centrifugal analyser (Roche Diagnostics Ltd, Welwyn Garden City, UK.).
+ Open protocol
+ Expand
4

Therapeutic Macrophages for Cirrhosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Albumin, alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP) and bilirubin levels were measured in serum using commercial kits (albumin, bilirubin, ALT: Alpha Laboratories Ltd.; AST, ALP; Randox Laboratories) adapted for use on a Cobas Fara centrifugal analyser (Roche Diagnostics).
As these initial murine experiments demonstrated human monocyte-derived macrophages (HMDMs) decreased these markers of liver injury and fibrosis and increased markers of regeneration we then proceeded to determine the possibility of generating human clinical-grade macrophages with a phenotype and function that would reflect the therapeutic macrophages in our model of cirrhotic disease with a view to macrophage therapy.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!